ICU Medical (NASDAQ:ICUI) Stock Rating Upgraded by StockNews.com

ICU Medical (NASDAQ:ICUI) was upgraded by research analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Tuesday.

A number of other equities research analysts also recently commented on ICUI. Raymond James set a $97.00 price objective on shares of ICU Medical in a research report on Wednesday, March 12th. Jefferies Financial Group raised ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 target price on the stock in a report on Wednesday, December 11th. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $168.67.

ICU Medical Stock Up 4.0 %

ICUI stock opened at $149.21 on Tuesday. The company’s 50 day moving average price is $156.96 and its 200 day moving average price is $164.86. The firm has a market capitalization of $3.66 billion, a price-to-earnings ratio of -32.65 and a beta of 0.73. ICU Medical has a fifty-two week low of $93.36 and a fifty-two week high of $196.26. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29.

Insider Transactions at ICU Medical

In other ICU Medical news, CEO Vivek Jain sold 1,373 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total transaction of $213,474.04. Following the transaction, the chief executive officer now owns 104,593 shares of the company’s stock, valued at approximately $16,262,119.64. This trade represents a 1.30 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 6.70% of the company’s stock.

Institutional Trading of ICU Medical

A number of large investors have recently made changes to their positions in ICUI. Arizona State Retirement System lifted its stake in ICU Medical by 1.0% in the fourth quarter. Arizona State Retirement System now owns 6,730 shares of the medical instruments supplier’s stock valued at $1,044,000 after buying an additional 65 shares during the last quarter. Huntington National Bank increased its holdings in shares of ICU Medical by 6.2% in the 4th quarter. Huntington National Bank now owns 1,402 shares of the medical instruments supplier’s stock valued at $218,000 after acquiring an additional 82 shares during the period. Equitable Trust Co. raised its position in ICU Medical by 1.6% in the 4th quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier’s stock valued at $822,000 after purchasing an additional 84 shares during the last quarter. LPL Financial LLC boosted its stake in ICU Medical by 2.0% during the 4th quarter. LPL Financial LLC now owns 4,816 shares of the medical instruments supplier’s stock worth $747,000 after purchasing an additional 93 shares during the period. Finally, Alliancebernstein L.P. grew its position in ICU Medical by 0.5% during the 4th quarter. Alliancebernstein L.P. now owns 26,107 shares of the medical instruments supplier’s stock worth $4,051,000 after purchasing an additional 136 shares during the last quarter. 96.10% of the stock is owned by institutional investors and hedge funds.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.